Aurora Cannabis ACB
NASDAQ ACB
$3.94 +0.13 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025)

Aurora Cannabis (ACB) posted quarterly Cash from Investing Activities of -$979864.6 for Q1 2025, up 67.9% year-over-year from -$583608.4 in Q1 2024, and up 57.38% quarter-over-quarter from -$2.3 million in Q4 2024.

Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has reported Cash from Investing Activities for 9 consecutive years, with -$979864.6 the latest figure, recorded in Q1 2025.

  • In Q1 2025, Cash from Investing Activities rose 67.9% year-over-year to -$979864.6; the TTM figure through Mar 2025 stood at -$6.0 million (up 88.19% YoY), while the FY2026 annual figure was -$53.1 million, down 522.19% from the prior year.
  • Cash from Investing Activities rose to -$979864.6 in Q1 2025 per ACB's latest filing, from -$2.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $25.8 million in Q4 2021 and bottomed at -$62.6 million in Q3 2022.
  • Historically, Cash from Investing Activities has averaged -$10.0 million across 5 years, with a median of -$2.7 million in 2024.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities jumped 770.37% — and 2022, when it sank 324.38%.
  • Aurora Cannabis' Cash from Investing Activities stood at $25.8 million in 2021, then slumped by 291.45% to -$49.5 million in 2022, then soared by 110.22% to $5.1 million in 2023, then plunged by 145.45% to -$2.3 million in 2024, then surged by 57.38% to -$979864.6 in 2025.
  • Business Quant data shows ACB's Cash from Investing Activities at -$979864.6 in Q1 2025, -$2.3 million in Q4 2024, and -$2.7 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -491.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Aurora Cannabis 243.01 Mn 170.70 Mn 25.75 Mn 895,704.41

Historic Data

Download Data
DateValue
Mar 31, 2025 -979,864.57
Mar 31, 2025 -979,864.57
Dec 31, 2024 -2.30 Mn
Dec 31, 2024 -2.30 Mn
Sep 30, 2024 -2.67 Mn
Sep 30, 2024 -2.67 Mn
Jun 30, 2024 -11,698.25
Jun 30, 2024 -11,698.25
Mar 31, 2024 -3.05 Mn
Mar 31, 2024 -3.05 Mn
Dec 31, 2023 5.06 Mn
Dec 31, 2023 5.06 Mn
Sep 30, 2023 -2.97 Mn
Sep 30, 2023 -2.97 Mn
Dec 31, 2022 -49.48 Mn
Dec 31, 2022 -49.48 Mn
Sep 30, 2022 -62.62 Mn
Sep 30, 2022 -62.62 Mn
Jun 30, 2022 -31.17 Mn
Jun 30, 2022 -31.17 Mn